Effects of individual risk factors on the incidence of cardiovascular event in the treated hypertensive patients of the Hypertension Optimal Treatment Study.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 11677378)

Published in J Hypertens on November 01, 2001

Authors

H Struijker-Boudier, M Safar, L van Bortel

Articles by these authors

(truncated to the top 100)

Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population. Hypertension (1997) 3.21

Improvement of internal jugular vein cannulation using an ultrasound-guided technique. Intensive Care Med (1997) 2.33

Pulse pressure and cardiovascular mortality in normotensive and hypertensive subjects. Hypertension (1998) 2.20

Risk factors and outcome of nosocomial infections: results of a matched case-control study of ICU patients. Am J Respir Crit Care Med (1998) 1.95

Increased systolic pressure in chronic uremia. Role of arterial wave reflections. Hypertension (1992) 1.78

Nosocomial acquisition of multiresistant Acinetobacter baumannii: risk factors and prognosis. Clin Infect Dis (1995) 1.74

Pulsatile versus steady component of blood pressure: a cross-sectional analysis and a prospective analysis on cardiovascular mortality. Hypertension (1989) 1.72

Influence of heart rate on mortality in a French population: role of age, gender, and blood pressure. Hypertension (1999) 1.71

Evaluation of the placebo effect and reproducibility of blood pressure measurement in hypertension. Am J Hypertens (2001) 1.66

Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis. J Hypertens (1998) 1.46

Sympathetic activation decreases medium-sized arterial compliance in humans. Am J Physiol (1994) 1.35

Remodeling of the radial artery in response to a chronic increase in shear stress. Hypertension (1996) 1.17

Pulse wave velocity as endpoint in large-scale intervention trial. The Complior study. Scientific, Quality Control, Coordination and Investigation Committees of the Complior Study. J Hypertens (2001) 1.16

Influence of angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients. Circulation (1996) 1.14

Flow-dependent vasodilation of brachial artery in essential hypertension. Am J Physiol (1990) 1.13

Arterial distensibility and left ventricular hypertrophy in patients with sustained essential hypertension. Am Heart J (1991) 1.12

Mechanisms of target organ damage caused by hypertension: therapeutic potential. Pharmacol Ther (2005) 1.11

Carotid artery distensibility and distending pressure in hypertensive humans. Hypertension (1994) 1.10

Elastic modulus of the radial artery wall material is not increased in patients with essential hypertension. Arterioscler Thromb (1994) 1.08

Aortic distensibility in normotensive, untreated and treated hypertensive patients. Blood Press (1995) 1.08

Mortality attributable to nosocomial infections in the ICU. Infect Control Hosp Epidemiol (1994) 1.07

Effects of chronic inhibition of converting enzyme on mechanical and structural properties of arteries in rat renovascular hypertension. Circ Res (1988) 1.05

Associations between heart rate and other risk factors in a large French population. J Hypertens (1999) 1.02

A decrease in diastolic blood pressure combined with an increase in systolic blood pressure is associated with a higher cardiovascular mortality in men. J Am Coll Cardiol (2000) 1.02

In vivo/in vitro comparison of rat abdominal aorta wall viscosity. Influence of endothelial function. Arterioscler Thromb Vasc Biol (1997) 1.01

Diagnostic and therapeutic implications of transesophageal echocardiography in medical ICU patients with unexplained shock, hypoxemia, or suspected endocarditis. Intensive Care Med (1996) 0.94

Aortic pulse wave velocity, an independent marker of cardiovascular risk. Arch Mal Coeur Vaiss (2002) 0.94

Arterial effects of salt restriction in hypertensive patients. A 9-week, randomized, double-blind, crossover study. J Hypertens (1992) 0.94

Genetically related human immunodeficiency virus type 1 in three adults of a family with no identified risk factor for intrafamilial transmission. J Virol (1998) 0.92

Regression of radial artery wall hypertrophy and improvement of carotid artery compliance after long-term antihypertensive treatment in elderly patients. J Am Coll Cardiol (1998) 0.92

Influence of angiotensin II type 1 receptor polymorphism on aortic stiffness in never-treated hypertensive patients. Hypertension (1995) 0.91

Comparative reactivity and mechanical properties of human isolated internal mammary and radial arteries. Cardiovasc Res (1998) 0.91

Accumulation of triglyceride-rich lipoprotein in subjects with abdominal obesity: the biguanides and the prevention of the risk of obesity (BIGPRO) 1 study. Arterioscler Thromb Vasc Biol (2001) 0.91

Arterial structure and function and environmental exposure to cadmium. Occup Environ Med (2007) 0.91

Angiotensin II type 1 receptor-153A/G and 1166A/C gene polymorphisms and increase in aortic stiffness with age in hypertensive subjects. J Hypertens (2001) 0.89

Influence of the angiotensin II type 1 receptor gene polymorphism on the effects of perindopril and nitrendipine on arterial stiffness in hypertensive individuals. Hypertension (1996) 0.88

Treatment with metformin of non-diabetic men with hypertension, hypertriglyceridaemia and central fat distribution: the BIGPRO 1.2 trial. Diabetes Metab Res Rev (2000) 0.87

Carotid artery tonometry: an accurate non-invasive method for central aortic pulse pressure evaluation. J Hypertens Suppl (1991) 0.87

Long-term blood pressure changes in renal homotransplantation. Arch Intern Med (1978) 0.87

Vascular changes in hemodialysis patients in response to recombinant human erythropoietin. Kidney Int (1989) 0.87

Arterial compliance in uraemia. J Hypertens Suppl (1989) 0.87

Increased stiffness of radial artery wall material in end-stage renal disease. Hypertension (1997) 0.87

Positive correlation between the blood pressure and heart rate response to the cold pressor test and the environmental temperature in older hypertensives. Am J Hypertens (1993) 0.86

Intravascular volume, extracellular fluid volume, and total body water in obese and nonobese hypertensive patients. Am J Cardiol (1983) 0.85

[Conn adenoma manifesting as reversible tetraparesis and rhabdomyolysis]. Rev Med Interne (1998) 0.85

Association between 24-hour ambulatory heart rate and arterial stiffness. J Hum Hypertens (2000) 0.85

Noninvasive detection of an increased vascular mass in untreated hypertensive patients. Am J Hypertens (1994) 0.84

Isobaric compliance of the radial artery is increased in patients with essential hypertension. J Hypertens (1993) 0.84

Placebo-controlled, randomized, double-blind study of intravenous enalaprilat efficacy and safety in acute cardiogenic pulmonary edema. Circulation (1996) 0.84

Carotid-artery dissection after a prolonged telephone call. N Engl J Med (1997) 0.84

Pulsed Doppler evaluation of diameter, blood velocity and blood flow of common carotid artery in sustained essential hypertension. J Cardiovasc Pharmacol (1985) 0.83

[Treatment of arterial hypertension with acebutolol. Double-blind study with placebos]. Nouv Presse Med (1975) 0.83

A dopamine transporter in human erythrocytes: modulation by insulin. Exp Physiol (1996) 0.83

Structural changes and in situ aortic pressure-diameter relationship in long-term chemical-sympathectomized rats. Am J Physiol (1995) 0.83

Arterial stiffening: opposing effects of age- and hypertension-associated structural changes. Can J Physiol Pharmacol (1996) 0.82

Taste-masked quinine sulphate pellets: bio-availability in adults and steady-state plasma concentrations in children with uncomplicated Plasmodium falciparum malaria. Ann Trop Paediatr (2008) 0.82

ANG II-induced Ca(2+) increase in smooth muscle cells from SHR is regulated by actin and microtubule networks. Am J Physiol (1999) 0.82

Acute changes in forearm haemodynamics produced by cigarette smoking in healthy normotensive non-smokers are not influenced by propranolol or pindolol. Eur J Clin Pharmacol (1992) 0.82

Central hypervolemia in the conscious rat: a model of cardiovascular deconditioning. J Appl Physiol (1985) (1996) 0.82

The vibratory pattern of ultrasonic files driven piezoelectrically. Int Endod J (1993) 0.82

Antihypertensive effect of sustained-release isosorbide dinitrate for isolated systolic systemic hypertension in the elderly. Am J Cardiol (1987) 0.81

Increased vasodilator response during stimulation of cardiopulmonary baroreceptors in borderline hypertensives. Clin Exp Pharmacol Physiol Suppl (1989) 0.80

Common carotid artery stiffness and patterns of left ventricular hypertrophy in hypertensive patients. Hypertension (1995) 0.80

Systolic Hypertension in Europe (Syst-Eur) trial phase 2: objectives, protocol, and initial progress. Systolic Hypertension in Europe Investigators. J Hum Hypertens (1999) 0.80

[Validation of Oscillomat, a device for self-measurement of blood pressure. Comparison with mercury sphygmomanometers]. Presse Med (1991) 0.80

Sympathetic activity in the rat: effects of anaesthesia on noradrenaline kinetics. J Auton Nerv Syst (2000) 0.80

Comparative effects of beta-adrenergic blockade in systolic hypertension according to age. Eur Heart J (1983) 0.80

Hemodynamics of the carotid artery after vasodilation in essential hypertension. Hypertension (1988) 0.79

Effects of ramipril on arterial hemodynamics. J Cardiovasc Pharmacol (1991) 0.79

Assessment of the acute arterial effects of converting enzyme inhibition in essential hypertension: a double-blind, comparative and crossover study. J Hum Hypertens (1998) 0.79

Noninvasive measurement of medium-sized artery intima-media thickness in humans: in vitro validation. J Vasc Res (1994) 0.79

Low-dose antihypertensive therapy with 1.5 mg sustained-release indapamide: results of randomised double-blind controlled studies. European study group. J Hypertens (1998) 0.79

Effects of bradykinin B2 receptor antagonism on the hypotensive effects of ACE inhibition. Br J Pharmacol (1994) 0.79

Efficacy, safety, and effects on quality of life of bisoprolol/hydrochlorothiazide versus amlodipine in elderly patients with systolic hypertension. Am Heart J (2000) 0.79

Mechanisms of methyclothiazide-induced inhibition of contractile responses in rat aorta. Eur J Pharmacol (2000) 0.79

The first report of the Systolic and Pulse Pressure (SYPP) Working Group. J Hypertens Suppl (1999) 0.79

Biventricular cardiac thrombosis during interleukin-2 infusion. N Engl J Med (2001) 0.79

The wall to lumen ratio of the radial artery in patients with Raynaud's phenomenon. J Vasc Res (1997) 0.79

Prevalence of cardiovascular risk factors in a French population. J Hypertens Suppl (1998) 0.79

Peripheral haemodynamic effects of smoking in habitual smokers. A methodological study. Eur J Clin Pharmacol (1990) 0.79

Effects of clonidine and flesinoxan on blood pressure variability in conscious spontaneously hypertensive rats. J Cardiovasc Pharmacol (1997) 0.78

Direct vascular actions of methyclothiazide and indapamide in aorta of spontaneously hypertensive rats. Fundam Clin Pharmacol (2001) 0.78

Vascular and cardiac effects of alpha-methyl-5-HT and DOI are mediated by different 5-HT receptors in the pithed rat. Eur J Pharmacol (1993) 0.78

Effects of clonidine on plasma catecholamines and neuropeptide Y in hypertensive patients at rest and during stress. J Cardiovasc Pharmacol (1993) 0.78

[Anti-hypertensive action of 3 drugs inhibiting the sympathetic nervous system. Hemodynamic and biological study]. Nouv Presse Med (1974) 0.78

Thromboxane B2 in borderline and essential hypertensive patients. Prostaglandins Leukot Med (1983) 0.78

Prevalence and circadian variations of ST-segment depression and its concomitant blood pressure changes in asymptomatic systemic hypertension. Am J Cardiol (1996) 0.78

[Primary aldosteronism. A risk factor for aortic dissection?]. J Mal Vasc (2003) 0.78

The effect of propofol on angiotensin II-induced Ca(2+) mobilization in aortic smooth muscle cells from normotensive and hypertensive rats. Anesth Analg (2000) 0.78

Salt sensitivity and bradykinin activity in rats. Agents Actions Suppl (1992) 0.78

Endogenous bradykinin activity in Dahl rats. J Cardiovasc Pharmacol (1993) 0.77

Opposite effects of remodeling and hypertrophy on arterial compliance in hypertension. Hypertension (1998) 0.77

Red blood cells participate in the metabolic clearance of catecholamines in the rat. Life Sci (1997) 0.77

Spontaneous renal artery dissection revealed by helical CT angiography. Eur Radiol (2000) 0.77

[Arterial compliance is not diminished in hypertensive patients when compared at the same level of blood pressure]. Arch Mal Coeur Vaiss (1994) 0.77

[Systemic arterial hypertension: pathogentic role of the sympathetic nervous system]. Nouv Presse Med (1977) 0.77

Effects of antihypertensive agents on carotid pulse contour in humans. J Hum Hypertens (1992) 0.77

Opposite effects of plasma homocysteine and the methylenetetrahydrofolate reductase C677T mutation on carotid artery geometry in asymptomatic adults. Arterioscler Thromb Vasc Biol (1998) 0.77

Adrenaline hypothesis: effect of formoterol on noradrenaline release. J Auton Pharmacol (2002) 0.77

Plasma erythrocyte relationship of catecholamines in human blood. J Cardiovasc Pharmacol (1994) 0.77